Every Cure’s Post

Ozempic and Wegovy stand out as compelling case studies in the repurposing of patented, profitable drugs. Their status encourages manufacturers to meet high demand, a dynamic that isn't always replicated in the realm of generic drugs, where profits may be marginal. The question then becomes, how do we incentivize generic manufacturers to scale up production when the margins are so thin? At Every Cure we are refining the landscape by matching the right drugs to the right patients and plan to work hand-in-hand with manufacturers to ensure those life-saving medications reach those who need them the most. I’d love to hear from you, what innovative strategies do you think could incentivize manufacturers to increase production of generic drugs? How can we all contribute to a healthcare system that not only discovers but also delivers these lifesaving treatments to those in need? #raredisease #pharma #drugdevelopment #drugdiscovery